Cargando...
Carfilzomib reverses pulmonary arterial hypertension
AIMS: Pulmonary arterial hypertension (PAH) remains a lethal disease with pronounced narrowing of pulmonary vessels due to abnormal cell growth. Agents that can reduce the pulmonary vascular thickness thus have therapeutic potential. The present study investigated the efficacy of carfilzomib (CFZ),...
Gardado en:
| Publicado en: | Cardiovasc Res |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado: |
Oxford University Press
2016
|
| Assuntos: | |
| Acceso en liña: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4836627/ https://ncbi.nlm.nih.gov/pubmed/26952044 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cvr/cvw047 |
| Tags: |
Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!
|